rxstatShortages › Somatropin

Somatropin (Genotropin, Saizen) shortage status

Shortage anticipated

Source: Health Canada shortage reports · Updated Jul 22, 2026

Also sold as: Genotropin, Saizen, Norditropin Nordiflex, Nutropin Aq Nuspin

A shortage of Somatropin is anticipated but not yet confirmed. 1 product(s) have anticipated-shortage reports on file with Health Canada.

A synthetic human growth hormone used to treat growth hormone deficiency.

Products affected
0 / 27
Reports on file
48

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Anticipated
GENOTROPIN
1.8MG · POWDER FOR SOLUTION · PFIZER CANADA ULC
DIN 02401827 · Demand increase for the drug.
Resolved
GENOTROPIN
0.4MG · POWDER FOR SOLUTION · PFIZER CANADA ULC
DIN 02401754 · ended Nov 25, 2025 · Demand increase for the drug.
Discontinued
NORDITROPIN FLEXPRO
5MG · SOLUTION · NOVO NORDISK CANADA INC
DIN 02529181
Resolved
NORDITROPIN FLEXPRO
5MG · SOLUTION · NOVO NORDISK CANADA INC
DIN 02529181 · ended Jul 23, 2025
Resolved
GENOTROPIN
1.6MG · POWDER FOR SOLUTION · PFIZER CANADA ULC
DIN 02401819 · ended Mar 21, 2025 · Demand increase for the drug.
Resolved
GENOTROPIN
0.6MG · POWDER FOR SOLUTION · PFIZER CANADA ULC
DIN 02401762 · ended Mar 19, 2025 · Demand increase for the drug.
Resolved
GENOTROPIN
0.2MG · POWDER FOR SOLUTION · PFIZER CANADA ULC
DIN 02401746 · ended Mar 11, 2025 · Demand increase for the drug.
Resolved
GENOTROPIN
5.3MG · POWDER FOR SOLUTION · PFIZER CANADA ULC
DIN 02401703 · ended Feb 26, 2025 · Demand increase for the drug.
Discontinued
NUTROPIN AQ NUSPIN 5
5MG · SOLUTION · HOFFMANN-LA ROCHE LIMITED
DIN 02399091
Discontinued
NUTROPIN AQ NUSPIN 10
10MG · SOLUTION · HOFFMANN-LA ROCHE LIMITED
DIN 02376393
Discontinued
NUTROPIN AQ NUSPIN 20
20MG · SOLUTION · HOFFMANN-LA ROCHE LIMITED
DIN 02399083
Resolved
GENOTROPIN
0.8MG · POWDER FOR SOLUTION · PFIZER CANADA ULC
DIN 02401770 · ended Nov 11, 2024 · Demand increase for the drug.

Showing 12 of 48 reports. All reports are on file with Health Canada.

What's happening

A manufacturer has told Health Canada it expects supply of Somatropin to fall short of demand. Anticipated shortages sometimes resolve without patients noticing; this page updates as soon as the status changes.

Somatropin is classified under “ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES” (ATC H01AC).

Recent changes

Common questions

What is Somatropin used for?

A synthetic human growth hormone used to treat growth hormone deficiency.

When will Somatropin be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Somatropin in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (anterior pituitary lobe hormones and analogues)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.